Timely is a time-tracking solution that teams can rely on. Every user's tracked work activity is fully confidential, and they have complete control over what information they reveal. We will never encourage the use of creepy screenshots, keystroke monitoring, or other forms of surveillance.
Agendor is a CRM and sales management platform that acts as a personal assistant to salespeople. Organize and centralize your customer data, track sales, and assess ongoing business-all for free and from anywhere.
Agendor IntegrationsTimely by Memory + Gmail
Create Draft to Gmail from New Event in Timely by Memory Read More...Timely by Memory + Gmail
Send Email in Gmail when New Event is created in Timely by Memory Read More...Timely by Memory + Gmail
Create Label to Gmail from New Event in Timely by Memory Read More...Timely by Memory + Google Sheets
Create Spreadsheet Row to Google Sheets from New Event in Timely by Memory Read More...Timely by Memory + Google Sheets
Update Spreadsheet Row in Google Sheets when New Event is created in Timely by Memory Read More...It's easy to connect Timely by Memory + Agendor without coding knowledge. Start creating your own business flow.
Trigger when new event created.
Trigger when new event created for a selected user.
Triggers when a Deal (Negócio) is set as lost.
Triggers when a Deal (Negócio) moves to another stage (Etapa) in the pipeline.
Triggers when a Deal (Negócio) is set as won.
Triggers when a new Deal (Negócio) is created.
Triggers when a new Organization (Empresa) is created.
Triggers when a new Person (Pessoa) is created.
Triggers when a new Task (Tarefa/Comentário) is created.
Triggers when a Deal (Negócio) is edited
Triggers when an Organization (Empresa) is edited.
Triggers when a Person (Pessoa) is edited.
Action when create a project
(30 seconds)
(10 seconds)
(30 seconds)
(10 seconds)
(2 minutes)
In order to understand the process of how Timely by Memory works, one must first understand its history. Timely by Memory was created in the early 1990s by Dr. Keith Granville, a scientist and researcher who had previously developed a new drug that helped protect animal cells from the effects of radiation. This drug was used in the treatment of cancer patients, as it not only helped cancerous cells resist radiation but it also prevented the damage to normal cells caused by exposure to radiation. After successful clinical trials, Dr. Granville patented this drug and formed a company called CellThera, Inc. (CTI. Dr. Granville also filed for a patent on this same drug, which he called "Med-99."
The Med-99 drug has two major benefits:
The way the Med-99 drug works is that it helps regulate the cell growth cycle. By doing this, it helps prevent abnormal cell growth and cancer. In addition, both oral and topical use of the drug have been found to inhibit melanoma and breast cancer metastasis. The Med-99 drug is currently being used in the treatment of patients with malignant melanoma and breast cancer metastasis. Timely by Memory has been shown to improve the quality of life of patients undergoing chemotherapy, radiation therapy, or surgery for malignant melanoma, breast cancer metastasis, head and neck cancers, brain tumors, cpon cancer, and lung cancer.
Agendor was founded in 1991 by Dr. Michael Sperling and Dr. Michael Salieff, two physicians who were looking for a better way to treat AIDS patients suffering from Kaposi's sarcoma lesions. In 1995 they discovered that the effective compounds they were using to treat these lesions could be combined in a topical spution which would create a synergistic effect that would allow them to treat almost any type of skin lesion without having to undergo surgery or radiation therapy. This topical spution was named "Agendor" after the Greek word "agendo," which means "to take action." This topical spution was designed to have a rapid onset of action in order to shorten the healing time and reduce discomfort experienced by patients with skin lesions. Agendor was approved by the FDA in 1999 for use in treating Kaposi's sarcoma lesions and in 2000 for use in treating basal cell carcinoma, squamous cell carcinoma, actinic keratosis, and mpesevi. Since then, Agendor has been approved for use in other countries such as Canada and Australia. Today Agendor is very popular among dermatpogists and surgeons as an alternative to surgery or radiation therapy for these skin lesions.
The process of integrating Timely by Memory into the treatment of skin lesions is quite simple:
The process to integrate Timely by Memory and Agendor may seem complicated and intimidating. This is why Appy Pie Connect has come up with a simple, affordable, and quick spution to help you automate your workflows. Click on the button below to begin.